SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cells
Philipp König(University of Bonn), Gerd Bendas(University of Bonn)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
August 6, 2024
Cited by 6
Related Papers
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells—Deciphering Novel Potential Targets for a Cell Sensitization
|Cancers|2018|34
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
|International Journal of Molecular Sciences|2020|30
Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
|International Journal of Molecular Sciences|2020|16
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
|Cancer Chemotherapy and Pharmacology|2023|12